NY-MEDIDATA
Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, has again been recognized as a Leader in Everest Group’s recently published “Decentralized Clinical Trials Platforms PEAK Matrix® Assessment 2023.” Medidata was the only provider to receive a “Star Performer” designation for the second consecutive year, reflecting its continued innovation and leadership.
The report evaluated the vision, capabilities, and market impact of 22 decentralized clinical trial (DCT) platform providers based on relevant customer case studies, revenue, key offerings, and their latest progress.
“Medidata’s unified platform harnesses DCT technology to optimize patient, site, and sponsor experiences, delivering more inclusive studies,” said Anthony Costello, chief executive officer, Medidata Patient Cloud, Medidata. “We’re honored to be recognized as a Leader by Everest Group in DCT platform providers, demonstrating our extensive experience and leadership in a rapidly evolving industry.”
In this year’s assessment, Medidata distinguished itself through substantial investments in next-generation and patient-centric DCT technologies within Medidata AI and Medidata Patient Cloud, such as the Medidata Diversity Program, the myMedidata application, and Medidata Rave Companion. As a Leader, Medidata was also recognized for its domain expertise and user experience for patients and sites, as well as its global capabilities to orchestrate DCTs.
“Medidata offers an end-to-end, comprehensive DCT platform, covering ePRO/eCOA, eConsent, televisits, patient recruitment, and engagement. With deep domain expertise, strategic partnerships, and industry experience, Medidata has achieved widespread adoption of its solutions,” said Nisarg Shah, practice director at Everest Group. “Its investments in building a unified experience for sites and patients have positioned Medidata as a Leader and a Star Performer in the Decentralized Clinical Trial Platforms PEAK Matrix Assessment 2023.”
Medidata’s platform has powered nearly 1,700 DCTs and over 1.1 million patients across disease areas, countries, languages, and clinical trial phases. With this technology, Medidata supports patient participation in the right trial at the right time, from anywhere and with easier, faster, and better results.
About Medidata
Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. With over 20 years of groundbreaking technological innovation across more than 30,000 trials and 9 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across 2,100+ customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. The company is a wholly owned subsidiary of Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA), which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization. Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.
About Dassault Systèmes
Dassault Systèmes, the 3DEXPERIENCE® Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all –consumers, patients, and citizens. Dassault Systèmes brings value to more than 300,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit www.3ds.com
© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systèmes, a European company (Societas Europaea) incorporated under French law, and registered with the Versailles trade and companies registry under number 322 306 440, or its subsidiaries in the United States and/or other countries.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240110694798/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hologic to be Acquired by Blackstone and TPG for up to $79 per Share21.10.2025 14:41:00 CEST | Press release
Hologic Stockholders to Receive $76 per Share in Cash Plus a Contingent Value Right of up to $3 per Share Payable Upon Achieving Certain Revenue MilestonesRepresents 46% Premium to Hologic’s Closing Price on Last Trading Day Prior to Media Reports of Possible TransactionTransaction Includes Significant Minority Investments from ADIA and GICTransaction Will Help Hologic Strengthen its Leadership in Women’s Health and Accelerate Growth Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into a definitive agreement to be acquired by funds managed by Blackstone (“Blackstone”) and TPG in a transaction valued at up to $79 per share, representing an enterprise value of up to $18.3 billion.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251021765122/en/ Under the terms of the agreement, Blackstone and TPG will acquire all outstanding Hologic shares for $76 per share in cash plus a non-tradable contingent value right (C
Axelera Announces Europa AIPU, Setting New Industry Benchmark for AI Accelerator Performance, Power Efficiency and Affordability21.10.2025 14:00:00 CEST | Press release
Delivers 629 TOPs processing power for multi-modal AI applications from the edge to the data center Axelera AI, the leading provider of purpose-built AI hardware acceleration technology, today announced Europa™, an AI processor unit (AIPU) that sets a new performance/price standard for multi-user generative AI and computer vision applications. Europa’s combination of processing power, energy and thermal efficiency, compact packaging, and multiple form factor options make it ideal for compute-intensive, multi-modal AI inference applications from the edge to enterprise servers. Designed to be cost effective and accessible, Europa enables any organization to unlock the power of cutting-edge AI applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251021493990/en/ Europa™ AIPU Next Gen Architecture for Real World AI Processing Power The Europa AIPU features eight second-generation AI cores, each incorporating Axelera’s ad
Enedym Inc. Secures Investment from Honda Motor Co., Ltd.21.10.2025 14:00:00 CEST | Press release
Enedym’s next generation switched reluctance motor (SRM) drive technology requires no permanent magnets or rare earth metals Enedym Inc. (“Enedym”), a technology company thatdevelops next generation switched reluctance motors (SRMs), electric powertrains, and powertrain controls, announced today an investment from Honda Motor Co., Ltd. (“Honda”). Honda invests in innovative startups through its global open innovation program, Honda Xcelerator Ventures. The new investment will be used to accelerate Enedym’s patented motor technology development and ramp up its operations. Enedym is headquartered at the McMaster Innovation Park in Hamilton, Ontario, Canada. Enedym has ownership of over 70 patents and pending patent applications and related inventions developed by the Canada Excellence Research Chair Laureate Dr. Ali Emadi and his research group at the McMaster Automotive Resource Centre (MARC), McMaster University. The Company is focused on the development of electric motors completely f
ExaGrid Named Finalist for the MSP Channel Awards 202521.10.2025 14:00:00 CEST | Press release
ExaGrid Nominated in 7 Categories for Inaugural Industry Awards ExaGrid®, the industry’s only Tiered Backup Storage solution with AI-Powered Retention Time-Lock (RTL) that includes a non-network-facing tier (tiered air gap), Auto Detect & Guard, delayed deletes and immutability for ransomware recovery, today announced that it has been nominated in six categories for the 1st annual MSP Channel Awards, which celebrates innovation across the IT Channel. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251021571422/en/ The new MSP Channel Awards build on the legacy of the former SDC Awards to better reflect today's fast-moving IT landscape. As managed services reshape how technology is delivered – from digital transformation and cybersecurity to cloud, data, and automation – these awards recognize the companies, partnerships, and individuals making a real impact across the channel. Voting to determine the winner in each category i
Carevance platform expands access to GE HealthCare’s clinical excellence with advanced patient monitoring and new perioperative hypotension management capability21.10.2025 14:00:00 CEST | Press release
Built on GE HealthCare’s 50+ years of clinical excellence in patient monitoring, Carevance is an advanced, reliable monitoring solution that leverages proprietary algorithms and proven technologies to help hospitals and clinicians deliver consistent, high-quality care. Designed for today’s clinical realities, Carevance helps support clinicians across acute care areas through an enhanced intra-hospital transport workflow and real-time patient data. As part of its capabilities, Carevance introduces the new Cardiac Output Insights feature available directly on the device to support caregivers in managing hemodynamic instability for perioperative care and help enable timely clinical interventions. Hemodynamic instability or hypotension is a common concern for care teams to manage during and after surgery, and can be associated with longer hospital stays and serious postoperative complications, such as organ failure and mortality.i,ii GE HealthCare (Nasdaq: GEHC) today announced it has rece
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom